WPA
VIR icon

Wealth Preservation Advisors’s Vir Biotechnology VIR Stock Holding History

Wealth Preservation Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.6K Buy
1,968
+31
+2% +$247 0.01% 331
2025
Q4 		$11.7K Hold
1,937
– – 0.01% 291
2025
Q3 		$11.1K Hold
1,937
– – 0.01% 284
2025
Q2 		$9.76K Hold
1,937
– – 0.01% 293
2025
Q1 		$12.6K Buy
+1,937
New +$17.2K 0.01% 298

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Wealth Preservation Advisors's VIR Position: Q1 2026 in Review

Wealth Preservation Advisors increased its Vir Biotechnology (VIR) stake by 1.6% in Q1 2026, buying an estimated $247 and bringing the position to 1,968 shares worth $17.6K. The position accounts for 0.01% of the portfolio, ranked #331.

Wealth Preservation Advisors first reported a position in VIR in Q1 2025 and has held it in 5 quarters since. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Wealth Preservation Advisors held 1,968 shares of Vir Biotechnology worth $17.6K as of Q1 2026.
  • Wealth Preservation Advisors bought 31 Vir Biotechnology shares in Q1 2026, an estimated $247.
  • Vir Biotechnology made up 0.01% of Wealth Preservation Advisors's portfolio in Q1 2026, its #331 holding.
  • Wealth Preservation Advisors first reported a position in Vir Biotechnology in Q1 2025 and has held it in 5 quarters since.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Wealth Preservation Advisors's 13F filing for Q1 2026, filed 15 May 2026.